Richard Bloomfield

Richard Bloomfield is an associate in Goodwin’s Technology and Life Sciences group who has significant experience of venture capital, M&A, and private equity transactions.

He has worked in a number of industry sectors and has particularly deep expertise in the technology sector, where he now focusses on supporting emerging technology and life sciences business including clients operating in the SaaS, fintech, insurtech, adtech, proptech, deep tech, and blockchain industries.

Richard is recognised as a “Key Lawyer” for venture capital and as a “Rising Star” for M&A in the Legal 500 industry publication.

Prior to joining Goodwin, Richard was a Senior Associate at Bird & Bird LLP and an Associate at Herbert Smith Freehills LLP working in London, Singapore, and Dubai. He has also been seconded to the legal teams of a technology business and an investment bank.

Richard’s experience includes:

• Advised Isometric on its $25 million seed financing round
• Advised Gensyn, a London based blockchain start-up, on the completion of its $43 million Series A fundraise
• Advised Citymapper on its sale to Via
• Advised Grey Wolf Therapeutics in its $49 million Series B financing
• Advising Kinnevik on its participation in Mews Systems $185 million Series C financing round
• Advising on numerous venture capital financings, both for companies and investors, ranging from early stage seed financings to acting for unicorns on their largest rounds
• Advising start-up accelerators
• Advising major US, European and Asian corporates, as well as founders and management teams, on cross-border M&A
• Advising private equity houses, companies and management teams on private equity transactions

Richard has been recognized by the Legal 500, 2022 and 2023 editions for his work in the Venture Capital space, which included the following client testimonial:

• “provided excellent commercial advice with great communication on a number of venture capital and M&A matters”

Richard has also been recognized by the Legal 500, three years consecutively (2021, 2022, and 2023) in the M&A, £50-500m category. Client testimonials noted:

• “Richard Bloomfield takes everything in his stride, acting with a maturity which belies his years. Very easy to work with”